Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > WA Providers

Dr. Dustan C. Osborn, PHD, MD

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

Dalhousie University Faculty of Medicine (1978)

1201 Bishop Road
Chehalis, WA 98532

(360) 345-1381

Dr. Dustan C. Osborn, PHD, MD is a medical oncologist in Chehalis, WA specializing in medical oncology, adult oncology and adult hematology. He graduated from Dalhousie University Faculty of Medicine in 1978 and has 46 years of experience. Dr. Dustan C. Osborn, PHD, MD is affiliated with STRAUB CLINIC AND HOSPITAL.

Office Locations

Address:

1201 Bishop Road
Chehalis, WA 98532

In The News

“Renee C. Byer/Seattle Post-Intelligencer Kine and his wife, Donna, confer with Dr. Dustan Osborn, at the Western Washington Cancer Treatment Center.”—Seattle Pi

biological response modifier (BRM) therapy	52
chemotherapy	52
doctor visit	1332
hospital care	176
inpatient care	176
minimally invasive procedures	117

**Gender**
Male	160
Female	260

**Ethnicity**
Non-Hispanic White	403
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	159
From 75 to 84	138
85 and over	68
Less than 65	55

Hypertension	58
High Cholesterol	44
Stroke	5
Ischemic Heart Disease	31
Depression	21
Chronic Kidney Disease	31
Asthma	8
Osteoperosis	12
Atrial Fibrilation	12
Heart Failure	25
Chronic Obstructive Pulmonary Disease	24
Diabetes	27
Dementia	10
Cancer	44

biological response modifier (BRM) therapy	96
chemotherapy	96
doctor visit	1596
hormone therapy	33
hospital care	169
inpatient care	169
minimally invasive procedures	161

**Gender**
Male	207
Female	270

**Ethnicity**
Non-Hispanic White	450
Black	0
Hispanic	0
Asian	11
Other	0
Native American	0

**Age**
From 65 to 74	184
From 75 to 84	169
85 and over	68
Less than 65	56

Hypertension	59
High Cholesterol	40
Stroke	8
Ischemic Heart Disease	37
Depression	19
Chronic Kidney Disease	37
Asthma	5
Osteoperosis	11
Atrial Fibrilation	13
Heart Failure	30
Chronic Obstructive Pulmonary Disease	23
Diabetes	27
Dementia	11
Cancer	44

biological response modifier (BRM) therapy	284
chemotherapy	284
doctor visit	1614
hormone therapy	42
hospital care	141
inpatient care	141
minimally invasive procedures	460
port flush	45

**Gender**
Male	406
Female	586

**Ethnicity**
Non-Hispanic White	938
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	406
From 75 to 84	352
85 and over	130
Less than 65	104

Hypertension	57
High Cholesterol	43
Stroke	4
Ischemic Heart Disease	28
Depression	20
Chronic Kidney Disease	37
Asthma	11
Osteoperosis	7
Atrial Fibrilation	12
Heart Failure	24
Chronic Obstructive Pulmonary Disease	21
Diabetes	27
Dementia	12
Cancer	45

biological response modifier (BRM) therapy	405
chemotherapy	405
doctor visit	1887
hormone therapy	68
hospital care	152
inpatient care	152
minimally invasive procedures	676
port flush	98

**Gender**
Male	256
Female	326

**Ethnicity**
Non-Hispanic White	546
Black	0
Hispanic	0
Asian	0
Other	11
Native American	0

**Age**
From 65 to 74	241
From 75 to 84	208
85 and over	73
Less than 65	60

Hypertension	62
High Cholesterol	42
Stroke	7
Ischemic Heart Disease	27
Depression	17
Chronic Kidney Disease	35
Asthma	24
Osteoperosis	9
Atrial Fibrilation	14
Heart Failure	26
Chronic Obstructive Pulmonary Disease	23
Diabetes	30
Dementia	10
Cancer	42

biological response modifier (BRM) therapy	431
chemotherapy	431
doctor visit	2009
hormone therapy	90
hospital care	130
inpatient care	130
minimally invasive procedures	726
port flush	137

**Gender**
Male	242
Female	333

**Ethnicity**
Non-Hispanic White	543
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	251
From 75 to 84	205
85 and over	78
Less than 65	41

Hypertension	64
High Cholesterol	40
Stroke	6
Ischemic Heart Disease	26
Depression	19
Chronic Kidney Disease	34
Asthma	7
Osteoperosis	11
Atrial Fibrilation	14
Heart Failure	21
Chronic Obstructive Pulmonary Disease	21
Diabetes	27
Dementia	10
Cancer	43

biological response modifier (BRM) therapy	424
blood draw	21
chemotherapy	424
doctor visit	1622
hormone therapy	85
hospital care	92
inpatient care	92
minimally invasive procedures	618
port flush	172

**Gender**
Male	265
Female	316

**Ethnicity**
Non-Hispanic White	545
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	230
From 75 to 84	221
85 and over	82
Less than 65	48

Hypertension	62
High Cholesterol	49
Stroke	7
Ischemic Heart Disease	28
Depression	21
Chronic Kidney Disease	37
Asthma	7
Osteoperosis	10
Atrial Fibrilation	13
Heart Failure	21
Chronic Obstructive Pulmonary Disease	19
Diabetes	31
Dementia	8
Cancer	41

biological response modifier (BRM) therapy	384
chemotherapy	384
doctor visit	1595
hormone therapy	53
hospital care	122
inpatient care	122
minimally invasive procedures	562
port flush	158

**Gender**
Male	243
Female	273

**Ethnicity**
Non-Hispanic White	491
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	200
From 75 to 84	194
85 and over	86
Less than 65	36

Hypertension	64
High Cholesterol	49
Stroke	5
Ischemic Heart Disease	31
Depression	21
Chronic Kidney Disease	41
Asthma	7
Osteoperosis	10
Atrial Fibrilation	15
Heart Failure	23
Chronic Obstructive Pulmonary Disease	20
Diabetes	28
Dementia	10
Cancer	44

biological response modifier (BRM) therapy	254
chemotherapy	254
doctor visit	1598
hormone therapy	60
hospital care	67
inpatient care	67
minimally invasive procedures	438
port flush	173

**Gender**
Male	230
Female	262

**Ethnicity**
Non-Hispanic White	455
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	191
From 75 to 84	184
85 and over	86
Less than 65	31

Hypertension	66
High Cholesterol	47
Stroke	6
Ischemic Heart Disease	35
Depression	22
Chronic Kidney Disease	41
Asthma	7
Osteoperosis	10
Atrial Fibrilation	17
Heart Failure	27
Chronic Obstructive Pulmonary Disease	19
Diabetes	28
Dementia	10
Cancer	44

biological response modifier (BRM) therapy	267
chemotherapy	267
doctor visit	1709
hormone therapy	37
hospital care	39
inpatient care	39
minimally invasive procedures	379
port flush	117

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Dustan C. Osborn, PHD, MD for Medicare patients.

The highest averages for the top procedures that Dr. Dustan C. Osborn, PHD, MD treated as a medical oncologist in Chehalis, WA were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hospital care.

biological response modifier (BRM) therapy	289
blood draw	21
chemotherapy	289
doctor visit	1663
hormone therapy	58
hospital care	120
inpatient care	120
minimally invasive procedures	459

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Dustan C. Osborn, PHD, MD.

**Gender**
Male	200
Female	262

**Ethnicity**
Black / African American	0
Asian / Pacific Islander	1
Non-Hispanic White	437
Native American / Alaskan Native	0
Hispanic	0
Other	1

**Age**
75 to 84	167
85 and over	67
Less than 65	43
65 to 74	186

Average of Total of Conditions of Medicare patients treated by Dr. Dustan C. Osborn, PHD, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Dustan C. Osborn, PHD, MD treated were hypertension, high cholesterol, cancer and chronic kidney disease.

Hypertension	49
High Cholesterol	35
Stroke	4
Ischemic Heart Disease	24
Depression	16
Chronic Kidney Disease	29
Asthma	7
Osteoporosis	8
Heart Failure	19
Chronic Obstructive Pulmonary Disease	17
Diabetes	22
Atrial Fibrillation	11
Cancer	34
Dementia	8

Education & Training

Dr. Dustan C. Osborn, PHD, MD graduated from Dalhousie University Faculty of Medicine in 1978. He has a state license in Montana.

Medical School: Dalhousie University Faculty of Medicine (1978)

Licensed In: Montana

Affiliations & Hospitals

Dr. Dustan C. Osborn, PHD, MD is associated with these hospitals and organizations:

STRAUB CLINIC AND HOSPITAL

Ratings & Reviews

Dr. Dustan C. Osborn, PHD, MD does not have any reviews yet, be the first to leave a review of Dr. Dustan C. Osborn, PHD, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Dustan C. Osborn, PHD, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Dendreon Corporation	$4,340 PROVENGE $4,340
Celgene Corporation	$3,912 Revlimid $3,502	Abraxane $238	Pomalyst $111	Istodax $37	$24
Novartis Pharmaceuticals Corporation	$2,407 TASIGNA $749	AFINITOR $277	SANDOSTATIN LAR $260	PROMACTA $249	NON BRAND $202	Other $671
Genentech USA, Inc.	$2,080 Kadcyla $484	TARCEVA $343	Avastin $315	Gazyva $276	Perjeta $161	Other $501
AstraZeneca Pharmaceuticals LP	$1,584 CALQUENCE $347	FASLODEX $325	TAGRISSO $271	IMFINZI $231	LYNPARZA $215	Other $193
Other	$10,713 IMBRUVICA $1,126	OPDIVO $550	JAKAFI $473	XTANDI $418	ELIQUIS $396	Other $7,749

**Types of Payments**
Food and Beverage	$16,006
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$3,000
Consulting Fee	$2,600
Travel and Lodging	$2,595
Education	$579
Other	$254

Ownership and Interest Payments

This table describes ownership payments received by Dr. Dustan C. Osborn, PHD, MD.

DARA Biosciences, Inc.

2014

$0.00

Physician Covered Recipient

None

Biography

Dr. Dustan Osborn is a medical specialist in adult hematology, adult oncology, and medical oncology. He attended medical school at Dalhousie University Faculty of Medicine.

Select Year:

Dr. Dustan C. Osborn, PHD, MD

Office Locations

In The News

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

2013 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Dustan C. Osborn, PHD, MD in 2013

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

2014 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Dustan C. Osborn, PHD, MD in 2014

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

2015 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Dustan C. Osborn, PHD, MD in 2015

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

2016 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Dustan C. Osborn, PHD, MD in 2016

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

2017 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Dustan C. Osborn, PHD, MD in 2017

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

2018 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Dustan C. Osborn, PHD, MD in 2018

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

2019 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Dustan C. Osborn, PHD, MD in 2019

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

2020 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Dustan C. Osborn, PHD, MD in 2020

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

Average Medicare Procedure Volume From 2013 - 2021

Average Medicare Patient Data From 2013 - 2021

Average of Total of Conditions of Medicare patients treated by Dr. Dustan C. Osborn, PHD, MD From 2013 - 2021

Education & Training

Affiliations & Hospitals

Ratings & Reviews

General Payments

Ownership and Interest Payments

Biography

Other Providers in Chehalis, WA